Epidemic control measures at NATO military base in Afghanistan during COVID-19 outbreak

The experience of American epidemiologists gained from the COVID-19 outbreak at NATO military base at Hamid Karzai international airport in Afghanistan can be quite useful. It can help to stop outbreaks of new unknown contagious diseases provoked by biological weapons.

Relevance. The contagious disease outbreaks at military forces location may tamper with their work. The newly appeared or unknown contagious diseases are the most dangerous ones in this sense, as their efficient detection, treatment and prevention tools have not been created yet.

Purpose of the study is to analyze epidemic control measures that were taken at NATO military base at Hamid Karzai international airport (as exemplified by the COVID-19 outbreak).

Study base sources. The authors have studied scientific journals in the English language available on the Internet (publication 2020–2021).

Method. Analytical.

Results. Large international airports are one of the main sources of contagious disease agents spreading to the nearest and farthest regions and countries. The American commanders took some quarantine measures at NATO military base at Hamid Karzai international airport to diminish the spreading of COVID-19 among the troops and reduce possible consequences. The comparison of values of the two group (quarantine and non-quarantine) detected that these groups were quite close in terms of parameter “Number of detected virus carriers (percentage)”. It means that these limitations are not enough to prevent COVID-19 from spreading.

Conclusions. The epidemic control measures taken at military bases and their subdivisions help to decrease contagious disease spreading, only if the contacts of the ill persons are traced. The military persons mostly fall ill with COVID-19 at their job sites.

1. Ge Y, Martinez L, Sun S, Chen Z, Handel A, Feng L, et al. COVID-19 Transmission Dynamics Among Close Contacts of Index Patients With COVID-19 JAMA Intern Med. 2021;181(10):1343. https://doi.org/10.1001/jamainternmed.2021.4686

2. Althouse B, Wenger E, Miller J, Scarpino S, Allard A, Hu H, et al. Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control Hu. PLoS Biol. 2020;18(11):e3000897. https://doi.org/10.1371/journal.pbio.3000897

3. Salahshoori I, Mobaraki-Asl A, Seyfaee N, Faraji M, Ganjkhani M, Hamrang A, et al. Mirzaei Nasirabad. Overview of COVID-19 Disease: Virology, Epidemiology, Prevention Diagnosis, Treatment, and Vaccines. Biologics. 2021;1(1):2–40. https://doi.org/10.3390/biologics1010002

4. Meyerowitz E, Richterman A, Gandhi R, Sax P Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors, P.E. Sax Ann Intern Med. 2021;174(1):69–79. https://doi.org/10.7326/M20-5008

5. Goldberg Y, Mandel M, Bar- On YM, Bodenheimer O, Freedman L, Ash N, Alroy-Preis S, Huppert A, Milo R, et al. Protection and waning of natural and hybrid COVID-19 immunity. medRxiv. 2021.12.04.21267114. https://doi.org/10.1101/2021.12.04.21267114

6. Lewis D. Mounting evidence suggests coronavirus is airborne—but health advice has not caught up. Nature. 2020;583(7817):510–3. https://doi.org/10.1038/d41586-020-02058-1

7. Tellier R, Li Y, Cowling B, Tang J. Recognition of aerosol transmission of infectious agents: a commentary. BMC Infect Dis. 2019;19(1):101. https://doi.org/10.1186/s12879-019-3707-y

8. Bazant M, Bush J. Guideline to limit indoor airborne transmission of COVID-19. Proc Natl Acad Sci USA. 2021;118(17):e2018995118. https://doi.org/10.1073/pnas.2018995118

9. Medby C, Larssen C, Norquay M, Killi H, Gurney J. Management of COVID-19 in a Deployed Setting. Military Medicine. 2023;188(3-4):e451–5. https://doi.org/10.1093/milmed/usab218

10. Kasper M, Geibe J, Sears C, Luse T, Olson N, DeLong G, et al. An outbreak of COVID-19 on an aircraſt carrier. N Engl J Med. 2020;383(25):2417–26. https://doi.org/10.1056/NEJMoa2019375

11. Ghandi M, Yokoe D, Havlir D. Asymptomatic transmission, the Achilles’ heel of COVID-19. Editorial published in N Engl J Med. 2020;382:2158–60. https://doi.org/10.1056/NEJMe2009758

12. Ghanchi A. Adaptation of the national plan for the prevention and fight against pandemic influenza to the 2020 COVID-19 epidemic in France. Disaster Med Public Health Prep. 2020;14(6):805–7. https://doi.org/10.1017/dmp.2020.82

13. Matos R, Chung K. DoD COVID-19 Practice Management Guide, Clinical Management of COVID-19, Operational Considerations for COVID-19: Planning and Preparation. Published online by the Department of Defense, March 4, 2020, P. 47.

14. Lauer S, Grantz K, Bi Q, Jones F, Zheng Q, Meredith H, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–82. https://doi.org/10.7326/M20-0504

15. Zhou F, Yu T, Du R, Fan G, Liu Y, Wang Y, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. https://doi.org/10.1016/S0140-6736(20)30566-3

16. Grasselli G, Zangrillo A, Antonelli M, Cabrini L, Castelli A, Zanella A, et al. Baseline characteristics and outcomes of 1,591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574–81. https://doi.org/10.1001/jama.2020.5394